Soc Telemed acquired by Patient Square Capital

UNITED STATES Software / Industry-Specific Software / Healthcare EV $300–700M

Context

SOC Telemed completed its acquisition by Patient Square Capital. The strategic rationale is rooted in SOC Telemed’s position as the largest national provider of acute‑care telemedicine in the US, with a scalable enterprise platform, Telemed IQ, and a diverse portfolio of specialty telemedicine services. For Patient Square, the acquisition aligns with a broader thesis of backing capital‑efficient, high‑margin, technology‑enabled healthcare solutions that can standardize and scale virtual care delivery across hospital and health‑system clients. The sponsor’s backing provides SOC Telemed with enhanced capital flexibility to invest in clinical capabilities, product innovation, and geographic expansion while maintaining its existing leadership under Chief Executive Officer Dr. Chris Gallagher.

Soc Telemed, which reported an EBITDA margin of [members only] in 2022, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average observed in the TMT (Tech, Media, Telecom) sector (15.2x in 2022).

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

SOC Telemed, Inc. is a leading national provider of acute care telemedicine technology and solutions, headquartered in Herndon, Virginia. Since 2004, the company has delivered virtual care programs across a broad range of clinical specialties for hospitals, health systems, post‑acute providers, physician networks, and value‑based care organizations. Its enterprise platform, Telemed IQ, is designed to rapidly deploy and centrally manage telemedicine services across the continuum of care, enabling clients to scale programs with minimal operational friction. The company’s business model centers on B2B telemedicine infrastructure and program management, combining technology licensing, professional services, and ongoing support. SOC Telemed offers multiple clinical service lines, including teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, and teleMaternal‑Fetal Medicine, making it one of the most comprehensive acute‑telemedicine vendors in the US. The platform’s enterprise‑grade architecture supports standardization, regulatory compliance, and integration with existing hospital workflows.

Ent. Value

$300–700M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2022

2021

Other operations with Patient Square Capital

Other operations with Patient Square Capital
Date	Acquirer	Target	Country	Sector
04/2025	PATIENT SQUARE CAPITAL	PATTERSON COMPANIES	UNITED STATES	Medical Consumables

Similar deals in Software

Similar deals in Software
Date	Acquirer	Target	Country	Sector
05/2022	CT ENGINEERING	INFODREAM	FRANCE	Supply Chain & Ops
05/2022	W.A.G PAYMENT SOLUTIONS	WEBEYE TELEMATICS	HUNGARY	Automotive
04/2022	SOGELINK	LOCATIQS	NETHERLANDS	Engineering & Design Software
04/2022	SOGELINK	FOCUS SOFTWARE	NORWAY	Engineering & Design Software
04/2022	VERVE	AXESINMOTION	SPAIN	Gaming & Consumer Apps
04/2022	MONTEFIORE INVESTMENT / PLÉIADE INVESTISSEMENT	GENERIX GROUP	FRANCE	Supply Chain & Ops
03/2022	BPIFRANCE / EURAZEO	DOCTOLIB	FRANCE	Healthcare
03/2022	CVC	RGI GROUP	ITALY	Financial Services / Banking
03/2022	APAX PARTNERS	ALCUMUS	UNITED KINGDOM	Industry-Specific Software
03/2022	ALBAREST / BPIFRANCE	MASA GROUP	FRANCE	Defense & Aerospace

REFERENCES

Valuation range: EV $300–700M

Revenue range: $100–200M

EV/Revenue range: 2x - 6x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Soc Telemed by Patient Square Capital are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: patient square capital

FAQ

What transaction does this page cover?

This page covers Patient Square Capital’s acquisition of 100% of Soc Telemed, an American company specialised in Industry-Specific Software, in 2022.

How was the acquisition of Soc Telemed by Patient Square Capital valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the $300–700M band and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What was Soc Telemed’s revenue at the time of the deal?

At the time of the transaction, Soc Telemed’s annual revenue was estimated within the $100–200M range (FY 2022). Detailed financial figures are available to members.

How does the valuation of Soc Telemed compare to benchmarks in the TMT (Tech, Media, Telecom) sector?

Transaction multiples for this specific deal are exclusively reserved for mynth members. Nevertheless, transactions tracked by mynth in this sector reveal an average benchmark multiple of 15.2x EBITDA during 2022.

What sources support the information on this transaction?

Information on this transaction is supported by three corroborating sources: an official corporate announcement published by the parties, independent reporting from specialized financial publications, as well as a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.